{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:40:31Z","timestamp":1790628031945,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ymeth.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T22:18:08Z","timestamp":1445552288000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Gene therapy in monogenic congenital myopathies"],"prefix":"10.1016","volume":"99","author":[{"given":"Xuan","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Childers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012 \u2013 an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J. Gene Med."},{"issue":"220","key":"10.1016\/j.ymeth.2015.10.004_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007523","article-title":"Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy","volume":"6","author":"Childers","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"20","key":"10.1016\/j.ymeth.2015.10.004_b0015","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/hmg\/11.20.2355","article-title":"Gene therapy of muscular dystrophy","volume":"11","author":"Chamberlain","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.ymeth.2015.10.004_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2012.91","article-title":"Clinical utility gene card for: centronuclear and myotubular myopathies","volume":"20","author":"Biancalana","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0025","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.22510","article-title":"Prevalence of congenital myopathies in a representative pediatric united states population","volume":"70","author":"Amburgey","year":"2011","journal-title":"Ann. Neurol."},{"issue":"Pt 4","key":"10.1016\/j.ymeth.2015.10.004_b0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/brain\/108.4.941","article-title":"Congenital centronuclear (myotubular) myopathy. A clinical, pathological and genetic study in eight children","volume":"108","author":"Heckmatt","year":"1985","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.ymeth.2015.10.004_b0035","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/oxfordjournals.hmg.a018913","article-title":"Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway","volume":"9","author":"Blondeau","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"Pt 8","key":"10.1016\/j.ymeth.2015.10.004_b0040","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1242\/jcs.118505","article-title":"Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo","volume":"126","author":"Amoasii","year":"2013","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.ymeth.2015.10.004_b0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0960-8966(02)00153-0","article-title":"Genotype-phenotype correlations in X-linked myotubular myopathy","volume":"12","author":"McEntagart","year":"2002","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","article-title":"Medical complications in long-term survivors with X-linked myotubular myopathy","volume":"134","author":"Herman","year":"1999","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0055","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0b013e3282efc157","article-title":"Genetic treatments in muscular dystrophies","volume":"20","author":"Muntoni","year":"2007","journal-title":"Curr. Opin. Neurol."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mt.2011.137","article-title":"Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy","volume":"20","author":"Fan","year":"2012","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0065","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudo typed with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.ymeth.2015.10.004_b0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ymthe.2005.03.005","article-title":"Altering AAV tropism with mosaic viral capsids","volume":"11","author":"Gigout","year":"2005","journal-title":"Mol. Ther."},{"issue":"15","key":"10.1016\/j.ymeth.2015.10.004_b0075","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne\u2019s muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.ymeth.2015.10.004_b0080","doi-asserted-by":"crossref","first-page":"21785","DOI":"10.1074\/jbc.M101877200","article-title":"Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of sarcoglycan assembly","volume":"276","author":"Zhu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat. Genet."},{"issue":"5999","key":"10.1016\/j.ymeth.2015.10.004_b0090","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0095","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp.2008.158261","article-title":"The myotonic dystrophies: diagnosis and management","volume":"81","author":"Turner","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum","volume":"60","author":"Day","year":"2003","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ymeth.2015.10.004_b0105","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/jnnp.2005.078881","article-title":"Respiratory involvement in inherited primary muscle conditions","volume":"77","author":"Shahrizaila","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.ymeth.2015.10.004_b0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.24249","article-title":"Respiratory assessment in centronuclear myopathies","volume":"50","author":"Smith","year":"2014","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R","article-title":"MTM1 mutations in X-linked myotubular myopathy","volume":"15","author":"Laporte","year":"2000","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.ymeth.2015.10.004_b0120","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00019052-200010000-00003","article-title":"Myotonic dystrophies","volume":"13","author":"Meola","year":"2000","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(99)00040-4","article-title":"Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population","volume":"164","author":"Vainzof","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneur.1966.00470070005001","article-title":"Myotubular myopathy. Persistence of fetal muscle in an adolescent boy","volume":"14","author":"Spiro","year":"1966","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.ymeth.2015.10.004_b0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-008-0472-1","article-title":"\u201cNecklace\u201d fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy","volume":"117","author":"Bevilacqua","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymeth.2015.10.004_b0145","article-title":"Facioscapulohumeral Muscular Dystrophy (FSHD): clinical medicine and molecular cell biology","author":"Cooper","year":"2004","journal-title":"Garland Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0150","first-page":"121","article-title":"Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients","volume":"70","author":"Nadaj-Pakleza","year":"2011","journal-title":"Folia Morphol (Warsz)"},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5858","key":"10.1016\/j.ymeth.2015.10.004_b0165","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymeth.2015.10.004_b0170","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/ncomms2550","article-title":"An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells","volume":"4","author":"Filareto","year":"2013","journal-title":"Nat. Commun."},{"issue":"165","key":"10.1016\/j.ymeth.2015.10.004_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004108","article-title":"Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy","volume":"4","author":"Corti","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"140","key":"10.1016\/j.ymeth.2015.10.004_b0180","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymeth.2015.10.004_b0185","series-title":"Genome Editing In Human Pluripotent Stem Cells","author":"Peters","year":"2008"},{"issue":"7006","key":"10.1016\/j.ymeth.2015.10.004_b0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ymeth.2015.10.004_b0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.ymeth.2015.10.004_b0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/geno.1996.0212","article-title":"A 900-kb cosmid contig and 10 new transcripts within the candidate region for myotubular myopathy (MTM1)","volume":"33","author":"Kioschis","year":"1996","journal-title":"Genomics"},{"issue":"10","key":"10.1016\/j.ymeth.2015.10.004_b0205","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1261\/rna.653607","article-title":"Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications","volume":"13","author":"Aartsma-Rus","year":"2007","journal-title":"RNA"},{"issue":"7","key":"10.1016\/j.ymeth.2015.10.004_b0210","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mt.2012.68","article-title":"RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy","volume":"20","author":"Wallace","year":"2012","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0215","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.22251","article-title":"Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D","volume":"68","author":"Mendell","year":"2010","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.ymeth.2015.10.004_b0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.gt.3301955","article-title":"Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions","volume":"10","author":"Furling","year":"2003","journal-title":"Gene Ther."},{"issue":"11","key":"10.1016\/j.ymeth.2015.10.004_b0225","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.2004.15.1065","article-title":"Phase I study of dystrophin plasmid-based gene therapy in Duchenne\/Becker muscular dystrophy","volume":"15","author":"Romero","year":"2004","journal-title":"Hum. Gene Ther."},{"issue":"12","key":"10.1016\/j.ymeth.2015.10.004_b0230","doi-asserted-by":"crossref","first-page":"e81302","DOI":"10.1371\/journal.pone.0081302","article-title":"Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy","volume":"8","author":"Finkel","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ymeth.2015.10.004_b0235","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.ymeth.2015.10.004_b0240","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ana.21732","article-title":"Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins","volume":"66","author":"Mendell","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymeth.2015.10.004_b0245","series-title":"An Introduction to Molecular Medicine and Gene Therapy","article-title":"Vectors of gene therapy","author":"Ponder","year":"2001"},{"key":"10.1016\/j.ymeth.2015.10.004_b0250","article-title":"Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins","author":"Lovric","year":"2012","journal-title":"Molecular"},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ymeth.2015.10.004_b0260","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/hum.2010.003","article-title":"Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle","volume":"21","author":"Qiao","year":"2010","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.ymeth.2015.10.004_b0265","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/mt.2011.22","article-title":"Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer","volume":"19","author":"Pulicherla","year":"2011","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","article-title":"Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle","volume":"28","author":"Asokan","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.ymeth.2015.10.004_b0275","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"15","key":"10.1016\/j.ymeth.2015.10.004_b0280","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1093\/nar\/15.15.6131","article-title":"Synthesis and hybridization studies on two complementary nona(2\u2032-O-methyl)ribonucleotides","volume":"15","author":"Inoue","year":"1987","journal-title":"Nucleic Acids Res."},{"issue":"5072","key":"10.1016\/j.ymeth.2015.10.004_b0285","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1126\/science.1502560","article-title":"Pseudo-half-knot formation with RNA","volume":"257","author":"Ecker","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/oli.1.1996.6.267","article-title":"Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation","volume":"6","author":"Hudziak","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"issue":"3","key":"10.1016\/j.ymeth.2015.10.004_b0295","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.1.1997.7.187","article-title":"Morpholino antisense oligomers: design, preparation, and properties","volume":"7","author":"Summerton","year":"1997","journal-title":"Antisense Nucleic Acid Drug Dev."},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/0883073811413581","article-title":"Gait assessment in children with duchenne muscular dystrophy during long-distance walking","volume":"27","author":"Ganea","year":"2012","journal-title":"J. Child Neurol."},{"issue":"9791","key":"10.1016\/j.ymeth.2015.10.004_b0305","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ymeth.2015.10.004_b0310","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/hmg\/ddn112","article-title":"AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis","volume":"17","author":"Buj-Bello","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0315","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/84839","article-title":"Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle","volume":"27","author":"Musaro","year":"2001","journal-title":"Nat. Genet."},{"issue":"2\u20133","key":"10.1016\/j.ymeth.2015.10.004_b0320","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-5273(02)00554-5","article-title":"Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors","volume":"90","author":"Vassalli","year":"2003","journal-title":"Int. J. Cardiol."},{"issue":"6338","key":"10.1016\/j.ymeth.2015.10.004_b0325","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/352815a0","article-title":"Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs","volume":"352","author":"Acsadi","year":"1991","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.ymeth.2015.10.004_b0330","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2014.08.032","article-title":"Gait characteristics in a canine model of X-linked myotubular myopathy","volume":"346","author":"Goddard","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.ymeth.2015.10.004_b0335","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm739","article-title":"Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery","volume":"8","author":"Hoshijima","year":"2002","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.ymeth.2015.10.004_b0340","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/humc.2013.147","article-title":"Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid alpha-glucosidase","volume":"24","author":"Conlon","year":"2013","journal-title":"Human Gene Ther. Clin. Develop."},{"key":"10.1016\/j.ymeth.2015.10.004_b0345","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-5-45","article-title":"A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of duchenne muscular dystrophy","volume":"5","author":"Rodino-Klapac","year":"2007","journal-title":"J. Transl. Med."},{"issue":"11","key":"10.1016\/j.ymeth.2015.10.004_b0350","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/mt.2014.151","article-title":"Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in duchenne patients","volume":"22","author":"Le Guiner","year":"2014","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.ymeth.2015.10.004_b0355","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.ymeth.2015.10.004_b0360","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/mt.2008.207","article-title":"A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs","volume":"16","author":"Yue","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymeth.2015.10.004_b0365","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-61737-982-6_21","article-title":"Whole body skeletal muscle transduction in neonatal dogs with AAV-9","volume":"709","author":"Yue","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0370","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/7439","article-title":"Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector","volume":"5","author":"Greelish","year":"1999","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0375","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.ymeth.2015.10.004_b0380","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/sj.mt.6300194","article-title":"The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophy","volume":"15","author":"Arruda","year":"2007","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.ymeth.2015.10.004_b0385","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1182\/blood-2009-12-261156","article-title":"Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B","volume":"115","author":"Arruda","year":"2010","journal-title":"Blood"},{"issue":"6413","key":"10.1016\/j.ymeth.2015.10.004_b0390","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/361647a0","article-title":"Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice","volume":"361","author":"Ragot","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0395","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1073\/pnas.98.1.42","article-title":"Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse","volume":"98","author":"Mann","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0400","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/104303401300042447","article-title":"Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease","volume":"12","author":"Pauly","year":"2001","journal-title":"Hum. Gene Ther."},{"issue":"7586","key":"10.1016\/j.ymeth.2015.10.004_b0405","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","article-title":"Comparison of treatment effects between animal experiments and clinical trials: systematic review","volume":"334","author":"Perel","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ymeth.2015.10.004_b0410","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24214","article-title":"Sildenafil does not improve cardiomyopathy in Duchenne\/Becker muscular dystrophy","author":"Leung","year":"2014","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0415","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/381039","article-title":"Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense","volume":"74","author":"Aartsma-Rus","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0420","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.scr.2013.12.004","article-title":"Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery","volume":"12","author":"Guan","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ymeth.2015.10.004_b0425","article-title":"Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations","author":"Dick","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"6","key":"10.1016\/j.ymeth.2015.10.004_b0430","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1242\/dmm.010082","article-title":"Zebrafish models flex their muscles to shed light on muscular dystrophies","volume":"5","author":"Berger","year":"2012","journal-title":"Dis. Model Mech."},{"issue":"17","key":"10.1016\/j.ymeth.2015.10.004_b0435","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1111\/febs.12412","article-title":"Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies","volume":"280","author":"Gibbs","year":"2013","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0440","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: zebrafish swim into view","volume":"8","author":"Lieschke","year":"2007","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0445","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pmr.2011.11.017","article-title":"Establishing clinical end points of respiratory function in large animals for clinical translation","volume":"23","author":"Goddard","year":"2012","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.ymeth.2015.10.004_b0450","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrg2578","article-title":"Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling","volume":"10","author":"Beckers","year":"2009","journal-title":"Nat. Rev. Genet."},{"issue":"7\u20138","key":"10.1016\/j.ymeth.2015.10.004_b0455","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00335-011-9348-0","article-title":"The function of dog models in developing gene therapy strategies for human health","volume":"22","author":"Nowend","year":"2011","journal-title":"Mamm. Genome"},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0460","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nmd.2004.10.019","article-title":"Canine and feline models of human inherited muscle diseases","volume":"15","author":"Shelton","year":"2005","journal-title":"Neuromuscul. Disord."},{"issue":"11","key":"10.1016\/j.ymeth.2015.10.004_b0465","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1038\/mt.2012.181","article-title":"Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping","volume":"20","author":"Vulin","year":"2012","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0470","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/hum.2011.147","article-title":"A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs","volume":"23","author":"Shin","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0475","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0480","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","article-title":"Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy","volume":"238","author":"Araki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0485","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ymeth.2015.10.004_b0490","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1083\/jcb.142.5.1279","article-title":"Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin","volume":"142","author":"Hack","year":"1998","journal-title":"J. Cell Biol."},{"issue":"23","key":"10.1016\/j.ymeth.2015.10.004_b0495","doi-asserted-by":"crossref","first-page":"15060","DOI":"10.1073\/pnas.212498399","article-title":"The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice","volume":"99","author":"Buj-Bello","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ymeth.2015.10.004_b0500","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/hmg\/ddr512","article-title":"Modeling the human MTM1 p. R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype","volume":"21","author":"Pierson","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymeth.2015.10.004_b0505","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0888-7543(92)90210-J","article-title":"An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy","volume":"13","author":"Sharp","year":"1992","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.ymeth.2015.10.004_b0510","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1939-1676.2008.0080.x","article-title":"Sarcoglycan-deficient muscular dystrophy in a Boston Terrier","volume":"22","author":"Deitz","year":"2008","journal-title":"J. Vet. Int. Med."},{"key":"10.1016\/j.ymeth.2015.10.004_b0515","doi-asserted-by":"crossref","DOI":"10.1002\/mus.23463","article-title":"Muscle function in a canine model of X-linked myotubular myopathy","author":"Grange","year":"2012","journal-title":"Muscle Nerve"},{"issue":"33","key":"10.1016\/j.ymeth.2015.10.004_b0520","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1073\/pnas.1003677107","article-title":"MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers","volume":"107","author":"Beggs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202315301237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202315301237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T05:05:35Z","timestamp":1572411935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202315301237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":104,"alternative-id":["S1046202315301237"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2015.10.004","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy in monogenic congenital myopathies","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}